Comparative prognostic implication of treatment response assessments in mCRPC: PERCIST 1.0, RECIST 1.1, and PSA response criteria.

Theranostics · 2020 · PMC7053201 · PMID 32194866

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

RECIST 1.1, which incorporates the use of CT data, showed a trend in distinguishing the OS of progressors vs. non-progressors, although not statistically significant in our study, yet was unable to distinguish survival differences between patients with responsive versus stable disease.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.